Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as compliance indicators and compensation for tooth eruption; Invisalign Assist treatment, which offers support to dental practitioners throughout the treatment process, including progress tracking; and Invisalign First Phase I and Invisalign First Comprehensive Phase II package for younger patients with early mixed dentition with a mixture of primary/baby and permanent teeth.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
Phone408-470-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.97 billion
Profitability
Miscellaneous
Employees11,660
Next Earnings Date10/23/2019 (Estimated)
OptionableOptionable
Align Technology (NASDAQ:ALGN) Frequently Asked Questions
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday, July, 24th. The medical equipment provider reported $1.26 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.13. The medical equipment provider had revenue of $600.70 million for the quarter, compared to analyst estimates of $599.86 million. Align Technology had a net margin of 19.06% and a return on equity of 29.26%. Align Technology's revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.30 earnings per share. View Align Technology's Earnings History.
When is Align Technology's next earnings date?
What guidance has Align Technology issued on next quarter's earnings?
Align Technology updated its third quarter earnings guidance on Wednesday, July, 24th. The company provided EPS guidance of $1.09-1.16 for the period, compared to the Thomson Reuters consensus estimate of $1.45. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $623.83 million.
What price target have analysts set for ALGN?
13 brokerages have issued 12 month target prices for Align Technology's shares. Their predictions range from $210.00 to $420.00. On average, they expect Align Technology's stock price to reach $294.40 in the next twelve months. This suggests a possible upside of 63.2% from the stock's current price. View Analyst Price Targets for Align Technology.
What is the consensus analysts' recommendation for Align Technology?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.
Has Align Technology been receiving favorable news coverage?
Media headlines about ALGN stock have been trending negative on Friday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Align Technology earned a news sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Align Technology.
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX) and ConforMIS (CFMS).
What other stocks do shareholders of Align Technology own?
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Mr. Joseph M. Hogan, Pres, CEO & Director (Age 62)
- Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 52)
- Mr. Stuart Hockridge, Sr. VP of Global HR (Age 47)
- Mr. Raphael S. Pascaud, Sr. VP of Bus. Devel. & Strategy (Age 47)
- Mr. Emory M. Wright, Sr. VP of Global Operations (Age 49)
Who are Align Technology's major shareholders?
Align Technology's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.93%), BlackRock Inc. (8.90%), BlackRock Inc. (8.90%), Private Advisor Group LLC (4.74%), Edgewood Management LLC (3.86%) and Polen Capital Management LLC (3.26%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.
Which major investors are selling Align Technology stock?
ALGN stock was sold by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Winslow Capital Management LLC, Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Janus Henderson Group PLC, BlackRock Inc., BlackRock Inc. and Bamco Inc. NY. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.
Which major investors are buying Align Technology stock?
ALGN stock was purchased by a variety of institutional investors in the last quarter, including Private Advisor Group LLC, Edgewood Management LLC, Nuveen Asset Management LLC, Invesco Ltd., Renaissance Technologies LLC, Man Group plc, Bessemer Group Inc. and Worldquant Millennium Advisors LLC. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.
How do I buy shares of Align Technology?
Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
One share of ALGN stock can currently be purchased for approximately $180.36.
How big of a company is Align Technology?
Align Technology has a market capitalization of $14.41 billion and generates $1.97 billion in revenue each year. The medical equipment provider earns $400.23 million in net income (profit) each year or $4.92 on an earnings per share basis. Align Technology employs 11,660 workers across the globe.View Additional Information About Align Technology.
What is Align Technology's official website?
How can I contact Align Technology?
Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]
MarketBeat Community Rating for Align Technology (NASDAQ ALGN)
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe ALGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
